Back

Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: Hong Kong-wide, observational, propensity score matched analysis

26 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Renal failure and cardiovascular disease 1 Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Wen Sun

The Chinese University of Hong Kong, Shatin (Hong Kong)

7 More presentations in this session

Presentation thumbnail
Association between global longitudinal strain and myocardial fibrosis biomarkers in patients with end-stage chronic kidney disease
Doctor C. Ureche (Iasi, RO)
Abstract Slides
Presentation thumbnail
The effect of the location of arteriovenous fistula on the right ventricle in end stage renal disease patients indicated for hemodialysis
Doctor S. Ali (Ismailia, EG)
Abstract Slides
Presentation thumbnail
Renal failure: a non-cardiac source of high sensitivity cardiac troponin T
Miss A. Papachristou (Basel, CH)
Abstract Slides
Presentation thumbnail
Impact of lifetime concentration of mannose on renal function: insights from mendelian randomization.
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Comparison of CT acquired valvular calcification scores in hemodialysis vs peritoneal dialysis patients undergoing open heart surgery
Doctor C. Kanaan (Phoenix, US)
Abstract Slides

Access the full session

Session thumbnail
Renal failure and cardiovascular disease 1

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources